EM Cases Febrile Infant risk stratification summary
Step-by-Step criteria recap
Pitfalls including reported fever and viral symptoms
AAP clinical practice guideline for well appearing febrile infants 8 to 60 days as adjacent evidence base for biomarker risk stratification
Decision tools
Decision support tools
Step-by-Step approach calculator
Clinical criteria and lab thresholds for 22 to 90 days
PECARN low risk rule for <=60 days
Urinalysis, ANC, procalcitonin thresholds
Aronson score for settings without procalcitonin
Point based risk estimation for invasive bacterial infection
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.